Literature DB >> 11273536

Stressful life-events, anxiety, depression and coping in patients of irritable bowel syndrome.

C Pinto1, M V Lele, A S Joglekar, V S Panwar, H S Dhavale.   

Abstract

UNLABELLED: A lot of research has pointed to a complex interaction between stressful life events, psychiatric morbidity and the irritable bowel syndrome (IBS). AIM: The present study aimed to determine the: stressful life-events in patients with irritable bowel syndrome patients in comparison to normal controls; effect of these events in causing clinically significant anxiety and depression; and the effect of psychopathology i.e. anxiety and depression on coping skills in these patients.
METHODOLOGY: Thirty patients with irritable bowel syndrome were compared with thirty matched normal controls, on the presumptive stressful life events scale and the mechanisms of coping scale. Further, among the irritable bowel syndrome patient group, the anxious and depressed subgroups were separated from the non-anxious and non-depressed subgroups using the hospital anxiety and depression scale. Positive and negative coping mechanisms between these subgroups were compared.
RESULTS: Significantly higher stress scores were found in the irritable bowel syndrome patient group than normal controls. Not all, but slightly more than fifty percent of irritable bowel syndrome had definite and clinically significant anxiety and/or depression. Those IBS patients with either definite depression tended to use predominantly negative coping styles as compared to those IBS patients without anxiety or depression.
CONCLUSION: Stressful life-event scores are significantly higher in IBS patients than in normal controls. Although not all of these patients have anxiety and/or depression, a significant number of patients show evidence of the same. Presence or absence of anxiety and/or depression influences how the patient with IBS copes with illness. Therefore, though further studies on the issue are required, we suggested that, as a supplement to medical management, recognition and treatment of anxiety and depression in this subgroup of IBS patients with psychotropic drugs and cognitive therapy for gaining more positive coping skills, may require special attention in the management of irritable bowel syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 11273536

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  13 in total

1.  The Treatment of Patients With Irritable Bowel Syndrome: Review of the Latest Data From the 2010 DDW Meeting.

Authors:  Mark Pimentel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

2.  Lifestyle and psychological factors related to irritable bowel syndrome in nursing and medical school students.

Authors:  Yukiko Okami; Takako Kato; Gyozen Nin; Kiyomi Harada; Wataru Aoi; Sayori Wada; Akane Higashi; Yusuke Okuyama; Susumu Takakuwa; Hiroshi Ichikawa; Motoyori Kanazawa; Shin Fukudo
Journal:  J Gastroenterol       Date:  2011-08-24       Impact factor: 7.527

3.  Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.

Authors:  Yong-Lan Huang; Jie-Ping Yu; Gao-Hua Wang; Zhen-Hua Chen; Qing Wang; Ling Xiao
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

4.  Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder.

Authors:  Gabriella Seres; Zoltán Kovács; Agota Kovács; Olga Kerékgyártó; Krisztina Sárdi; Pál Demeter; Eszter Mészáros; Ferenc Túry
Journal:  J Clin Psychol Med Settings       Date:  2008-09-30

5.  Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).

Authors:  Mariette Bengtsson; Oskar Hammar; Thomas Mandl; Bodil Ohlsson
Journal:  BMC Gastroenterol       Date:  2011-11-10       Impact factor: 3.067

6.  Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment.

Authors:  Majid Mahvi-Shirazi; Ali Fathi-Ashtiani; Sayed-Kazem Rasoolzade-Tabatabaei; Mohsen Amini
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

Review 7.  The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.

Authors:  Changhyun Lee; Eunyoung Doo; Ji Min Choi; Seung-Ho Jang; Han-Seung Ryu; Ju Yup Lee; Jung Hwan Oh; Jung Ho Park; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

8.  A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students.

Authors:  Yan-Yan Dong; Fei-Xue Chen; Yan-Bo Yu; Chao Du; Qing-Qing Qi; Han Liu; Yan-Qing Li
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

9.  A prospective study of the psychobehavioral factors responsible for a change from non-patient irritable bowel syndrome to IBS patient status.

Authors:  Yasushi Fujii; Shinobu Nomura
Journal:  Biopsychosoc Med       Date:  2008-09-25

10.  Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.

Authors:  Chen Xie; Yurong Tang; Yunfeng Wang; Ting Yu; Yun Wang; Liuqin Jiang; Lin Lin
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.